Seres Therapeutics Inc (MCRB) Company Profile & Statistics

Seres Therapeutics Inc
MCRB
(Nasdaq - US)
Open
0.77
-0.05 (-5.88%)
in:usd•As of: Nov 21, 2024 12:37 UTC -5
Open
0.81
High
0.88
Low
0.74

About Seres Therapeutics Inc

CEO

Eric D. Shaff

Headquarters

101 cambridgepark drive

cambridge, ma 02140, united states

Auditor

PricewaterhouseCoopers LLP

Employees

160

Share Holders

Website

www.serestherapeutics.com

Industry

biotechnology

Sector

health technology

Company Overview

Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Seres Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	130.79M
Enterprise Value	63.96M
Enterprise Value/EBITDA (ttm)	-0.48
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.90
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-2757.24%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-606.30%
Return on Assets (ttm)	-55.08%

Income Statement

Revenue (ttm)	374.00K
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	374.00K
EBITDA (ttm)³	-134.62M
Net Income Avi to Common (ttm)	-25.48M
Diluted EPS (ttm)	-0.23

Share Statistics

Beta (5Y Monthly)	2.06
52-Week Change	-21.04%
S&P500 52-Week Change	30.92%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	170.74M
Dividend Yield	0.00%
Float ⁴	162.03M
% Held by Insiders	5.10%
% Held by Institutions	59.34%

Balance Sheet

Total Cash (mrq)	66.82M
Total Cash Per Share (mrq)	0.39
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	1.12%
Quick Ratio (mrq)	1.12%
Book Value Per Share (mrq)	0.14

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.72
Free Cash Flow (ytd)	-110.02M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Seres Therapeutics Inc

Trade With A Regulated Broker